Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

HPV PATRICIA Study Group

doi:10.1016/S1470-2045(11)70287-X

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

HPV PATRICIA Study Group

Research output: Contribution to journal › Article › Scientific › peer-review

364 Citations (Scopus)

Original language	English
Pages (from-to)	100-110
Journal	LANCET ONCOLOGY
Volume	13
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(11)70287-X
Publication status	Published - 2012
Publication type	A1 Journal article-refereed

Keywords

human papillomavirus

Publication forum classification

Publication forum level 3

Access to Document

10.1016/S1470-2045(11)70287-X

Cite this

@article{c9c9d74efa1e4efb998c3e9a3abdd908,

title = "Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial",

keywords = "human papillomavirus, human papillomavirus",

author = "{HPV PATRICIA Study Group} and Wheeler, {Cosette M} and Henry Kitchener and Teixeira, {J{\'u}lio C} and Skinner, {Rachel S} and Unnop Jaisamrarn and Genara Limson and Barbara Romanowski and FY Aoki and Schwarz, {Tino F} and Poppe, {Willy A} and Bosch, {Xavier F} and Xavier Castellsagu{\'e} and Harper, {Diane M} and Warmer Huh and Karin Hardt and Toufik Zahaf and Dominique Descamps and Frank Struyf and Gary Dubin and Matti Lehtinen and SuzanneM Garland and Anne Szarewski and Jorma Paavonen and Paulo Naud and Jorge Salmer{\'o}n and Sang-Nan Chow and Dan Apter",

year = "2012",

doi = "10.1016/S1470-2045(11)70287-X",

language = "English",

volume = "13",

pages = "100--110",

journal = "LANCET ONCOLOGY",

issn = "1470-2045",

publisher = "Elsevier",

number = "1",

}

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. / HPV PATRICIA Study Group.

In: LANCET ONCOLOGY, Vol. 13, No. 1, 2012, p. 100-110.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

AU - HPV PATRICIA Study Group

AU - Wheeler, Cosette M

AU - Kitchener, Henry

AU - Teixeira, Júlio C

AU - Skinner, Rachel S

AU - Jaisamrarn, Unnop

AU - Limson, Genara

AU - Romanowski, Barbara

AU - Aoki, FY

AU - Schwarz, Tino F

AU - Poppe, Willy A

AU - Bosch, Xavier F

AU - Castellsagué, Xavier

AU - Harper, Diane M

AU - Huh, Warmer

AU - Hardt, Karin

AU - Zahaf, Toufik

AU - Descamps, Dominique

AU - Struyf, Frank

AU - Dubin, Gary

AU - Lehtinen, Matti

AU - Garland, SuzanneM

AU - Szarewski, Anne

AU - Paavonen, Jorma

AU - Naud, Paulo

AU - Salmerón, Jorge

AU - Chow, Sang-Nan

AU - Apter, Dan

PY - 2012

Y1 - 2012

KW - human papillomavirus

U2 - 10.1016/S1470-2045(11)70287-X

DO - 10.1016/S1470-2045(11)70287-X

M3 - Article

VL - 13

SP - 100

EP - 110

JO - LANCET ONCOLOGY

JF - LANCET ONCOLOGY

SN - 1470-2045

IS - 1

ER -